Ascidian Therapeutics, Inc
Clinical trials sponsored by Ascidian Therapeutics, Inc, explained in plain language.
-
First-Ever human test of gene therapy for rare, blinding eye disease begins
Disease control Recruiting nowThis is the first human trial of an experimental gene therapy called ACDN-01 for people with ABCA4-related eye diseases like Stargardt disease. The study will test the safety and early signs of effectiveness of a single injection into the eye. Fifteen adult participants will be f…
Phase: PHASE1, PHASE2 • Sponsor: Ascidian Therapeutics, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Finding the right people for future vision trials
Knowledge-focused Recruiting nowThis study aims to identify people with specific inherited eye diseases, like Stargardt disease, who might be eligible for future treatment trials. It will recruit 50 participants to perform tests that check their genetic profile and eye health. The goal is to create a pool of pr…
Sponsor: Ascidian Therapeutics, Inc • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:24 UTC